New Jersey Fosamax Femur Fracture Trial Update

Glynn v. Merck Sharp & Dohme Corp. (3:11-cv-05304, U.S. District Court, District of New Jersey) started trial in April 2013.  Evidence was presented from internal documents and experts from both sides as to the benefits and risks of Fosamax.  The jury was asked to decide if Fosamax was defective, whether Merck provided adequate warnings, and [...]